Skip to content

VALN

Valneva SE

NASDAQ · Healthcare · Biotechnology · FR

$6.56
−0.15%
Ask drillr
Institutional positioning

13F filings over the trailing two quarters

New 11Increased 9Reduced 7Sold out 7
FilerActionSharesFiled
Frazier Life Sciences Management, L.P.Unchanged2,291,666Aug 14, 2026
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Unchanged2,291,666May 15, 2026
NOVO HOLDINGS A/SReduced1,057,421May 15, 2026
Vivo Capital, LLCNew Position763,199Aug 14, 2026
GENERAL AMERICAN INVESTORS CO INCUnchanged354,361May 1, 2026
GENERAL AMERICAN INVESTORS CO INCUnchanged354,361Jul 31, 2026
MILLENNIUM MANAGEMENT LLCNew Position135,223Aug 14, 2026
WELLS FARGO & COMPANY/MNReduced78,029Jul 8, 2026
WELLS FARGO & COMPANY/MNReduced77,214Aug 14, 2026
MORGAN STANLEYIncreased56,217Aug 13, 2026
MORGAN STANLEYReduced46,925May 15, 2026
IRONWOOD INVESTMENT MANAGEMENT LLCIncreased45,064Aug 14, 2026
IRONWOOD INVESTMENT MANAGEMENT LLCUnchanged25,135May 15, 2026
HRT FINANCIAL LPNew Position20,847May 14, 2026
CITADEL ADVISORS LLCNew Position20,294Sep 2, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings